Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
Naoki Hama(Hokkaido University), Ken‐ichiro Seino(Hokkaido University), Heekyung Lee(Seoul National University), Nabeel Kajihara(Hokkaido University), Nanumi Han(Hokkaido University), Yoshinori Hasegawa(Kazusa DNA Research Institute), Hideo Yagita∥(Juntendo University), Haruka Wada(Hokkaido University), Ryo Otsuka(Hokkaido University), Fumihito Kitagawa(Hokkaido University), Muhammad Baghdadi(Hokkaido University), Takuto Kobayashi(Hokkaido University), Hwanseok Rhee(National Cancer Center)
Cited by 26
Related Papers
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832
The transcriptional landscape and mutational profile of lung adenocarcinoma
|Genome Research|2012|599
Differential binding properties of B7-H1 and B7-DC to programmed death-1
|Biochemical and Biophysical Research Communications|2003|206